<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p58" style="overflow: hidden; position: relative; background-color: white; width: 1210px; height: 935px;">
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<style type="text/css" >

#t1_58{left:36px;bottom:25px;letter-spacing:0.07px;word-spacing:0.01px;}
#t2_58{left:341px;bottom:30px;}
#t3_58{left:348px;bottom:25px;letter-spacing:0.11px;}
#t4_58{left:377px;bottom:30px;}
#t5_58{left:381px;bottom:25px;letter-spacing:0.07px;word-spacing:-0.1px;}
#t6_58{left:540px;bottom:30px;}
#t7_58{left:546px;bottom:25px;letter-spacing:0.07px;}
#t8_58{left:44px;bottom:77px;letter-spacing:0.1px;word-spacing:-0.05px;}
#t9_58{left:44px;bottom:63px;letter-spacing:0.1px;}
#ta_58{left:285px;bottom:860px;letter-spacing:-0.32px;word-spacing:0.06px;}
#tb_58{left:285px;bottom:827px;letter-spacing:-0.24px;}
#tc_58{left:996px;bottom:873px;letter-spacing:-0.1px;}
#td_58{left:1043px;bottom:853px;letter-spacing:-0.22px;word-spacing:0.13px;}
#te_58{left:1093px;bottom:833px;letter-spacing:-0.09px;}
#tf_58{left:1095px;bottom:47px;letter-spacing:0.38px;}
#tg_58{left:1121px;bottom:28px;letter-spacing:0.19px;word-spacing:-0.15px;}
#th_58{left:36px;bottom:270px;}
#ti_58{left:46px;bottom:264px;letter-spacing:0.08px;word-spacing:-0.01px;}
#tj_58{left:377px;bottom:264px;letter-spacing:0.12px;}
#tk_58{left:407px;bottom:264px;letter-spacing:0.13px;}
#tl_58{left:481px;bottom:264px;}
#tm_58{left:36px;bottom:253px;}
#tn_58{left:46px;bottom:247px;letter-spacing:0.11px;word-spacing:0.02px;}
#to_58{left:45px;bottom:231px;letter-spacing:0.12px;word-spacing:0.01px;}
#tp_58{left:36px;bottom:220px;}
#tq_58{left:46px;bottom:214px;letter-spacing:0.12px;word-spacing:-0.03px;}
#tr_58{left:556px;bottom:214px;}
#ts_58{left:36px;bottom:203px;}
#tt_58{left:46px;bottom:197px;letter-spacing:0.12px;}
#tu_58{left:45px;bottom:180px;letter-spacing:0.12px;word-spacing:0.01px;}
#tv_58{left:45px;bottom:163px;letter-spacing:0.14px;}
#tw_58{left:36px;bottom:152px;}
#tx_58{left:46px;bottom:146px;letter-spacing:0.1px;word-spacing:-0.09px;}
#ty_58{left:45px;bottom:130px;letter-spacing:0.13px;}
#tz_58{left:45px;bottom:113px;letter-spacing:0.14px;}
#t10_58{left:438px;bottom:778px;letter-spacing:0.39px;word-spacing:-0.22px;}
#t11_58{left:764px;bottom:786px;}
#t12_58{left:36px;bottom:748px;letter-spacing:-0.24px;}
#t13_58{left:36px;bottom:729px;letter-spacing:-0.1px;}
#t14_58{left:351px;bottom:737px;letter-spacing:-0.12px;}
#t15_58{left:36px;bottom:711px;}
#t16_58{left:47px;bottom:711px;letter-spacing:-0.09px;}
#t17_58{left:36px;bottom:693px;letter-spacing:-0.1px;}
#t18_58{left:41px;bottom:674px;}
#t19_58{left:58px;bottom:674px;letter-spacing:-0.09px;word-spacing:-0.05px;}
#t1a_58{left:721px;bottom:674px;letter-spacing:-0.12px;}
#t1b_58{left:794px;bottom:674px;letter-spacing:-0.06px;}
#t1c_58{left:63px;bottom:656px;}
#t1d_58{left:76px;bottom:656px;letter-spacing:-0.09px;}
#t1e_58{left:41px;bottom:638px;}
#t1f_58{left:58px;bottom:638px;letter-spacing:-0.09px;}
#t1g_58{left:63px;bottom:619px;}
#t1h_58{left:76px;bottom:619px;letter-spacing:-0.09px;}
#t1i_58{left:547px;bottom:627px;}
#t1j_58{left:36px;bottom:546px;letter-spacing:-0.09px;}
#t1k_58{left:36px;bottom:528px;letter-spacing:-0.11px;word-spacing:0.01px;}
#t1l_58{left:36px;bottom:509px;letter-spacing:-0.1px;}
#t1m_58{left:625px;bottom:232px;}
#t1n_58{left:635px;bottom:226px;letter-spacing:0.09px;word-spacing:0.01px;}
#t1o_58{left:634px;bottom:209px;letter-spacing:0.11px;word-spacing:-0.08px;}
#t1p_58{left:634px;bottom:192px;letter-spacing:0.12px;word-spacing:0.01px;}
#t1q_58{left:634px;bottom:176px;letter-spacing:0.14px;}
#t1r_58{left:625px;bottom:165px;letter-spacing:0.08px;}
#t1s_58{left:642px;bottom:159px;letter-spacing:0.09px;word-spacing:0.02px;}
#t1t_58{left:634px;bottom:142px;letter-spacing:0.12px;}
#t1u_58{left:634px;bottom:125px;letter-spacing:0.12px;}
#t1v_58{left:634px;bottom:108px;letter-spacing:0.1px;word-spacing:0.03px;}
#t1w_58{left:23px;bottom:915px;letter-spacing:-0.14px;}

.s0_58{font-size:9px;font-family:ArialMT_5tg;color:#000;}
.s1_58{font-size:5px;font-family:ArialMT_5tg;color:#000;}
.s2_58{font-size:12px;font-family:Arial-BoldMT_5te;color:#000;}
.s3_58{font-size:28px;font-family:Arial-BoldMT_5te;color:#000;}
.s4_58{font-size:17px;font-family:ArialMT_5tg;color:#0065A4;}
.s5_58{font-size:17px;font-family:Arial-BoldMT_5te;color:#000;}
.s6_58{font-size:12px;font-family:ArialMT_5tg;color:#000;}
.s7_58{font-size:15px;font-family:ArialMT_5tg;color:#0065A4;}
.s8_58{font-size:15px;font-family:ArialMT_5tg;color:#000;}
.s9_58{font-size:15px;font-family:ArialMT_k0;color:#000;}
.sa_58{font-size:14px;font-family:Arial-BoldMT_5te;color:#000;}
.sb_58{font-size:17px;font-family:Arial-BoldMT_jz;color:#000;}
.sc_58{font-size:17px;font-family:Webdings_k6;color:#000;}
.sd_58{font-size:17px;font-family:Arial-BoldMT_5te;color:#0065A4;}
.se_58{font-size:17px;font-family:SymbolMT_ka;color:#000;}
.sf_58{font-size:11px;font-family:Helvetica, Arial, sans-serif;color:#000;}
</style>
<style id="fonts58" type="text/css" >

@font-face {
	font-family: Arial-BoldMT_5te;
	src: url("fonts/Arial-BoldMT_5te.woff") format("woff");
}

@font-face {
	font-family: Arial-BoldMT_jz;
	src: url("fonts/Arial-BoldMT_jz.woff") format("woff");
}

@font-face {
	font-family: ArialMT_5tg;
	src: url("fonts/ArialMT_5tg.woff") format("woff");
}

@font-face {
	font-family: ArialMT_k0;
	src: url("fonts/ArialMT_k0.woff") format("woff");
}

@font-face {
	font-family: SymbolMT_ka;
	src: url("fonts/SymbolMT_ka.woff") format("woff");
}

@font-face {
	font-family: Webdings_k6;
	src: url("fonts/Webdings_k6.woff") format("woff");
}

</style>
<div id="pg58Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg58" style="-webkit-user-select: none;"><object width="1210" height="935" data="58/58.svg" type="image/svg+xml" id="pdf58" style="width:1210px; height:935px; z-index: 0;"></object></div>
<div class="text-container"><span id="t1_58" class="t s0_58">Version 4.2024, 5/1/2024 © 2024 National Comprehensive Cancer Network </span>
<span id="t2_58" class="t s1_58">® </span>
<span id="t3_58" class="t s0_58">(NCCN </span>
<span id="t4_58" class="t s1_58">® </span>
<span id="t5_58" class="t s0_58">), All rights reserved. NCCN Guidelines </span>
<span id="t6_58" class="t s1_58">® </span>
<span id="t7_58" class="t s0_58">and this illustration may not be reproduced in any form without the express written permission of NCCN. </span>
<span id="t8_58" class="t s2_58">Note: All recommendations are category 2A unless otherwise indicated. </span>
<span id="t9_58" class="t s2_58">Clinical Trials: NCCN believes that the best management of any patient with cancer is in a clinical trial. Participation in clinical trials is especially encouraged. </span>
<span id="ta_58" class="t s3_58">NCCN Guidelines Version 4.2024 </span>
<span id="tb_58" class="t s3_58">Cancer of the Supraglottic Larynx </span>
<span id="tc_58" class="t s4_58">NCCN Guidelines Index </span>
<span id="td_58" class="t s4_58">Table of Contents </span>
<span id="te_58" class="t s4_58">Discussion </span>
<span id="tf_58" class="t s5_58">SUPRA-A </span>
<span id="tg_58" class="t s5_58">2 OF 2 </span>
<span id="th_58" class="t s6_58">1 </span>
<span id="ti_58" class="t s7_58">See Principles of Radiation Techniques (RAD-A) </span><span id="tj_58" class="t s8_58">and </span><span id="tk_58" class="t s7_58">Discussion</span><span id="tl_58" class="t s8_58">. </span>
<span id="tm_58" class="t s6_58">4 </span>
<span id="tn_58" class="t s8_58">Suggest 44–50 Gy in 3D-CRT and sequentially planned IMRT or 54–63 Gy with </span>
<span id="to_58" class="t s8_58">IMRT dose painting technique (dependent on dose per fraction). </span>
<span id="tp_58" class="t s6_58">5 </span>
<span id="tq_58" class="t s7_58">Principles of Systemic Therapy for Non-Nasopharyngeal Cancers (SYST-A)</span><span id="tr_58" class="t s8_58">. </span>
<span id="ts_58" class="t s6_58">7 </span>
<span id="tt_58" class="t s9_58">Bernier J, Domenge C, Ozsahin M, et al. Postoperative irradiation with or without </span>
<span id="tu_58" class="t s8_58">concomitant chemotherapy for locally advanced head and neck cancer. N Engl J </span>
<span id="tv_58" class="t s8_58">Med 2004;350:1945-1952. </span>
<span id="tw_58" class="t s6_58">8 </span>
<span id="tx_58" class="t s8_58">Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy </span>
<span id="ty_58" class="t s8_58">and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N </span>
<span id="tz_58" class="t s8_58">Engl J Med 2004;350:1937-1944. </span>
<span id="t10_58" class="t s5_58">PRINCIPLES OF RADIATION THERAPY </span>
<span id="t11_58" class="t sa_58">1 </span>
<span id="t12_58" class="t s5_58">POSTOPERATIVE: </span>
<span id="t13_58" class="t s5_58">RT or Concurrent Systemic Therapy/RT </span>
<span id="t14_58" class="t sa_58">5,7-10 </span>
<span id="t15_58" class="t s5_58">• </span><span id="t16_58" class="t sb_58">Preferred interval between resection and postoperative RT is ≤6 weeks. </span>
<span id="t17_58" class="t s5_58">• PTV </span>
<span id="t18_58" class="t sc_58"></span><span id="t19_58" class="t s5_58">High risk: Adverse pathologic features such as positive margins (see footnote j on </span><span id="t1a_58" class="t sd_58">SUPRA-3</span><span id="t1b_58" class="t s5_58">). </span>
<span id="t1c_58" class="t se_58">◊ </span><span id="t1d_58" class="t s5_58">60–66 Gy (2.0 Gy/fraction); daily Monday–Friday in 6–6.5 weeks </span>
<span id="t1e_58" class="t sc_58"></span><span id="t1f_58" class="t s5_58">Low to intermediate risk: Sites of suspected subclinical spread </span>
<span id="t1g_58" class="t se_58">◊ </span><span id="t1h_58" class="t s5_58">44–50 Gy (2.0 Gy/fraction) to 54–63 Gy (1.6–1.8 Gy/fraction) </span>
<span id="t1i_58" class="t sa_58">4 </span>
<span id="t1j_58" class="t s5_58">Either IMRT (preferred) or 3D-CRT is recommended. Use of proton therapy is an area of active investigation. </span>
<span id="t1k_58" class="t s5_58">Proton therapy may be considered when normal tissue constraints cannot be met by photon-based therapy, or when photon-based therapy </span>
<span id="t1l_58" class="t s5_58">causes compromise of standard radiation dosing to tumor or postoperative volumes. </span>
<span id="t1m_58" class="t s6_58">9 </span>
<span id="t1n_58" class="t s8_58">Bernier J, Cooper JS, Pajak TF, et al. Defining risk levels in locally advanced </span>
<span id="t1o_58" class="t s8_58">head and neck cancers: A comparative analysis of concurrent postoperative </span>
<span id="t1p_58" class="t s8_58">radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501). </span>
<span id="t1q_58" class="t s8_58">Head Neck 2005;27:843-850. </span>
<span id="t1r_58" class="t s6_58">10 </span>
<span id="t1s_58" class="t s8_58">Cooper JS, Zhang Q, Pajak TF, et al. Long-term follow-up of the RTOG </span>
<span id="t1t_58" class="t s8_58">9501/intergroup phase III trial: postoperative concurrent radiation therapy and </span>
<span id="t1u_58" class="t s8_58">chemotherapy in high-risk squamous cell carcinoma of the head and neck. Int J </span>
<span id="t1v_58" class="t s8_58">Radiat Oncol Biol Phys 2012;84:1198-1205. </span>
<span id="t1w_58" class="t sf_58">Printed by Fredd Merc on 8/29/2024 4:45:54 AM. For personal use only. Not approved for distribution. Copyright © 2024 National Comprehensive Cancer Network, Inc., All Rights Reserved. </span></div>

</div>
</body>
</html>
